Health & Fitness
Health and Fitness
Health and Fitness
Thu, September 22, 2011
Wed, September 21, 2011
Ironwood Pharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference
CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--[ Ironwood Pharmaceuticals, Inc. ] (NASDAQ: IRWD) will present at the Jefferies 2011 Global Healthcare Conference in London on Wednesday, September 28, 2011, at 9:20 a.m. British Summer Time / 4:20 a.m. Eastern Daylight Time.
A live webcast of Ironwooda™s presentation will be accessible through the Investors section of the companya™s website at [ www.ironwoodpharma.com ]. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwooda™s website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwooda™s GC-C agonist, is an investigational drug for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation. The efficacy portion of linaclotidea™s development program has been completed and supports the recently submitted NDA for both indications, as well as the anticipated MAA submission for the IBS-C indication. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is located in Cambridge, Mass. To learn more, visit [ www.ironwoodpharma.com ].
